DRW Securities’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,400
Closed -$227K 703
2024
Q3
$227K Sell
1,400
-2,000
-59% -$319K 0.01% 488
2024
Q2
$498K Buy
3,400
+1,900
+127% +$283K 0.02% 328
2024
Q1
$237K Buy
+1,500
New +$239K 0.01% 314
2023
Q2
Sell
-7,200
Closed -$1.12M 399
2023
Q1
$1.12M Sell
7,200
-12,400
-63% -$2M 0.02% 131
2022
Q4
$3.46M Sell
19,600
-36,400
-65% -$6.28M 0.09% 64
2022
Q3
$9.15M Buy
56,000
+30,700
+121% +$5.2M 0.19% 40
2022
Q2
$4.49M Sell
25,300
-17,000
-40% -$3.03M 0.11% 58
2022
Q1
$7.5M Buy
42,300
+37,800
+840% +$6.43M 0.2% 44
2021
Q4
$770K Sell
4,500
-7,700
-63% -$1.26M 0.02% 108
2021
Q3
$1.97M Buy
12,200
+8,900
+270% +$1.52M 0.09% 79
2021
Q2
$544K Buy
+3,300
New +$546K 0.02% 175

Other funds holding JNJ

DRW Securities's JNJ Position: Q2 2026 in Review

DRW Securities sold out of Johnson & Johnson (JNJ) in Q2 2026, closing a stake of 8,867 shares — an estimated $2.16M sold.

DRW Securities first reported a position in JNJ in Q3 2016 and held it in 19 quarters. The position peaked at $5.53M in Q1 2025. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • DRW Securities reported no remaining Johnson & Johnson position as of Q2 2026 after selling out during the quarter.
  • DRW Securities sold 8,867 Johnson & Johnson shares in Q2 2026, an estimated $2.16M.
  • DRW Securities first reported a position in Johnson & Johnson in Q3 2016 and held it in 19 quarters.
  • DRW Securities's Johnson & Johnson position peaked at $5.53M in Q1 2025.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on DRW Securities's 13F filing for Q2 2026, filed 14 Aug 2026.